Values of debulking surgery for unresectable well-differentiated metastatic pancreatic neuroendocrine tumors:a comparative study
作者机构:Department of Pancreato-Biliary SurgeryThe First Affiliated HospitalSun Yat-sen UniversityGuangzhouGuangdongP.R.China Department of GastroenterologyThe First Affiliated HospitalSun Yat-sen UniversityGuangzhouGuangdongP.R.China
出 版 物:《Gastroenterology Report》 (胃肠病学报道(英文))
年 卷 期:2023年第11卷第1期
页 面:247-253页
核心收录:
学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
主 题:pancreatic neuroendocrine tumor metastasis debulking surgery prognosis
摘 要:Background and objective:The value of debulking surgery for unresectable well-differentiated metastatic pancreatic neuroendocrine tumor(m-PNET)remains poorly *** study aimed to evaluate the outcomes of m-PNET following debulking surgery in our ***:Patients with well-differentiated m-PNET in our hospital between February 2014 and March 2022 were *** and long-term outcomes of patients treated with radical resection,debulking surgery,and conservative therapy were compared ***:Fifty-three patients with well-differentiated m-PNET were reviewed,including 47 patients with unresectable m-PNET(debulking surgery,25;conservative therapy,22)and 6 patients with resectable m-PNET(radical resection).Patients undergoing debulking surgery had a post-operative Clavien–DindoIII complication rate of 16.0%without *** 5-year overall survival(OS)rate of patients treated with debulking surgery was significantly higher than that of those treated with conservative therapy alone(87.5%vs 37.8%,log-rank P=0.022).Besides,the 5-year OS rate of patients treated with debulking surgery was comparable to that of patients with resectable m-PNET undergoing radical resection(87.5%vs 100%,log-rank P=0.724).Conclusions:Patients with unresectable well-differentiated m-PNET who underwent resection had better long-term outcomes than those who received conservative therapy *** 5-year OS of patients undergoing debulking surgery and radical resection were *** surgery could be considered for patients with unresectable well-differentiated m-PNET if no contraindication exists.